Precision BioSciences to Present at Upcoming Investor Conferences

Rhea-AI Summary

Precision BioSciences (DTIL), a clinical-stage biotechnology firm, announced its participation in two upcoming investor conferences. The Jefferies Virtual Healthcare Conference will take place on June 3, 2020, where CEO Matt Kane will speak from 9:30 AM to 9:55 AM ET. Following that, the company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, with Kane speaking from 8:50 AM to 9:30 AM ET. Live webcasts can be accessed on the company’s website, with replays available for 30 days post-presentation.

DURHAM, N.C., May 26, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS^® genome editing platform today announced its participation in the following upcoming investor conferences:

• Jefferies Virtual Healthcare Conference
  Date: Wednesday, June 3, 2020
  Time: 9:30 – 9:55 AM ET
  Speaker: Matt Kane, Chief Executive Officer and co-founder
   
• Goldman Sachs 41^st Annual Global Healthcare Conference
  Date: Thursday, June 11, 2020
  Time: 8:50 – 9:30 AM ET
  Speaker: Matt Kane, Chief Executive Officer and co-founder

Live webcasts of each presentation will be accessible on the Company’s website, www.PrecisionBiosciences.com, under the Investors & Media section. An archived replay of the webcasts will be available for 30 days following the presentations.

About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS^® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist. Elo Life Systems is a wholly-owned subsidiary of Precision BioSciences also using ARCUS to benefit human health and wellness with novel food products that enhance the nutrition and diversity of global food supply. For more information about Precision BioSciences please visit www.precisionbiosciences.com.

Contact:
Maurissa Messier
Senior Director, Corporate Communications
Maurissa.messier@precisionbiosciences.com

Josh Rappaport
Stern Investor Relations
josh.rappaport@sternir.com

FAQ

When is Precision BioSciences participating in the Jefferies Virtual Healthcare Conference?

Precision BioSciences will participate in the Jefferies Virtual Healthcare Conference on June 3, 2020, from 9:30 AM to 9:55 AM ET.

What is the date and time of Precision BioSciences' presentation at the Goldman Sachs Conference?

Precision BioSciences will present at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, from 8:50 AM to 9:30 AM ET.

Who is the speaker for Precision BioSciences at the upcoming investor conferences?

Matt Kane, the CEO and co-founder of Precision BioSciences, will be the speaker at both upcoming investor conferences.

Where can I watch the webcasts of Precision BioSciences' presentations?

Live webcasts of Precision BioSciences' presentations can be accessed on their website, under the Investors & Media section.

Will there be a replay available for Precision BioSciences' presentations?

Yes, an archived replay of the webcasts will be available for 30 days following the presentations.